BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 19140508)

  • 1. [Metabolic effects of mexidol in complex treatment of chronic brain ischemia].
    Demchenko EIu; Kulakova NV; Semiglazova TA; Golovacheva AB; Borodulina EV; Udut VV
    Eksp Klin Farmakol; 2008; 71(6):13-5. PubMed ID: 19140508
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The neuroprotective therapy of outpatient treatment of chronic cerebral ischemia].
    Berezhnaya SV; Yakupov EZ
    Zh Nevrol Psikhiatr Im S S Korsakova; 2015; 115(6):48-52. PubMed ID: 26356397
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The study of the efficacy and safety of Mexidol and Mexidol Forte 250 in patients with chronic cerebral ischemia].
    Kutashov VA; Ulyanova OV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2019; 119(12. Vyp. 2):89-92. PubMed ID: 32207723
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The assessment of the clinical efficacy, vasoactive and metabolic effects of mexidol in elderly patients with discirculatory encephalopathy].
    Abramenko IuV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2011; 111(11 Pt 1):35-41. PubMed ID: 22611676
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Cerebrovascular and antiserotoninergic activity of the combination of tropoxin and mexidol].
    Gorbunov AA; Gan'shina TS; Turilova AI; Mirzoian RS
    Eksp Klin Farmakol; 2011; 74(8):23-7. PubMed ID: 22232910
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Results of the sequential use of Mexidol and Mexidol Forte 250 in patients with chronic cerebral ischemia].
    Abramenko YV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2020; 120(3. Vyp. 2):59-64. PubMed ID: 32307432
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Immune and oxygen disturbances in patients with chronic cerebral ischemia and their correction].
    Konoplya AI; Laskov VB; Shul'ginova AA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2015; 115(11):28-32. PubMed ID: 26978048
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Efficacy and safety of the drug mexidol FORTE 250 as part of sequential therapy in patients with chronic ischemia of the brain].
    Chukanova EI; Chukanova AS
    Zh Nevrol Psikhiatr Im S S Korsakova; 2019; 119(9):39-45. PubMed ID: 31626217
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Adaptogenic effects of mexidol in chronic cerebral ischemia].
    Antipenko EA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2012; 112(3 Pt 1):44-9. PubMed ID: 22677755
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The use of mexidol in chronic cerebral ischemia].
    Lyang OV; Kochetov AG
    Zh Nevrol Psikhiatr Im S S Korsakova; 2013; 113(12):126-9. PubMed ID: 24596977
    [No Abstract]   [Full Text] [Related]  

  • 11. [The efficacy of combination therapy with mexidol and cerebrolysin in chronic cerebral ischemia].
    Berezhnaya SV; Yakupov EZ; Zaharov YA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2016; 116(5):23-27. PubMed ID: 27240176
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Possibilities of antioxidant therapy for asthenia and cognitive deficit in elderly patients with chronic brain ischemia].
    Duma SN
    Ter Arkh; 2013; 85(12):100-5. PubMed ID: 24640678
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Efficacy of emoxipine and mexidol in patients with chronic disorders of the digestive system and atherosclerosis of the abdominal aorta].
    Dolgushina AI
    Eksp Klin Farmakol; 2011; 74(12):11-4. PubMed ID: 22379875
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Use of galidor in therapy of chronic brain ischemia].
    Boĭko AN; Kamchatnov PR; Izmailov AM; Gaponova OV; Kabanov AA; Batysheva TT
    Zh Nevrol Psikhiatr Im S S Korsakova; 2005; Suppl 15():45-50. PubMed ID: 16447553
    [No Abstract]   [Full Text] [Related]  

  • 15. [The results of the study of the efficacy and safety of mexidol in patients with chronic cerebral ischemia].
    Chukanova EI; Chukanova AS; Mamayeva KI
    Zh Nevrol Psikhiatr Im S S Korsakova; 2015; 115(2):71-74. PubMed ID: 26081329
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effect of mexidol on clinical and biochemical parameters of perinatal hypoxia in newborn children].
    Levitina EV
    Eksp Klin Farmakol; 2001; 64(5):34-6. PubMed ID: 11764497
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The anti-ischemic effects of 3-hydroxypyridine derivatives in cerebrovascular pathology].
    Pogorelyĭ VE; Arl't AV; Gaevyĭ MD; Gatsura VV; Smirnov LD
    Eksp Klin Farmakol; 1999; 62(5):15-7. PubMed ID: 10572744
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Complex therapy of acute and exacerbated chronic nonspecific parotitis including mexidol and non-coherent infrared therapy].
    Deriabin EI; Shumikhina LA
    Stomatologiia (Mosk); 2006; 85(3):21-3. PubMed ID: 16858317
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The use of mexidol in psychiatric practice].
    Kosenko VG; Karagezian EA; Luneva LV; Smolenko LF
    Zh Nevrol Psikhiatr Im S S Korsakova; 2006; 106(6):38-41. PubMed ID: 16841482
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antihypoxic and antinecrotic effect of mexidol in skin ischemia.
    Galenko-Yaroshevskii VP; Bagmetova EN; Fil'chukova IA; Sidel'nikov AY; Popkov VA; Gorelashvili AS; Antelava NA; Sukoyan GV
    Bull Exp Biol Med; 2005 Feb; 139(2):202-6. PubMed ID: 16027807
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.